Form 8-K - Current report:
SEC Accession No. 0000874716-23-000074
Filing Date
2023-05-19
Accepted
2023-05-19 16:00:19
Documents
14
Period of Report
2023-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20230517.htm   iXBRL 8-K 55687
6 idxx-20230517_g1.jpg GRAPHIC 47794
  Complete submission text file 0000874716-23-000074.txt   334824

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20230517.xsd EX-101.SCH 2244
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20230517_def.xml EX-101.DEF 15015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20230517_lab.xml EX-101.LAB 29099
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20230517_pre.xml EX-101.PRE 15587
8 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20230517_htm.xml XML 11656
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 23939869
SIC: 2835 In Vitro & In Vivo Diagnostic Substances